Pathology · Year 2 · from Pathology
Case 2: Coagulation Workup - Prolonged PTT
Patient Demographics
- Age: 8 years
- Sex: Male
- Occupation: Second-grade student
Chief Complaint
"He's having surgery next week and his preoperative blood work came back abnormal."
History of Present Illness
An 8-year-old boy is referred for evaluation of an isolated prolonged PTT discovered on preoperative labs for an elective tonsillectomy. His PTT is 58 seconds (normal 25-35 seconds), and his PT is normal at 12 seconds. He has no history of abnormal bleeding. His mother reports that he has had multiple dental extractions without excessive bleeding, normal healing from cuts and scrapes, and no spontaneous bruising or bleeding. He has never had surgery before. There is no family history of bleeding disorders.
Past Medical History
- Recurrent tonsillitis (indication for surgery)
- No prior surgeries or significant bleeding
- No prior transfusions
Family History
- No known bleeding disorders
- No history of excessive bleeding in parents or siblings
Physical Examination
- Vital Signs: Normal for age
- General: Well-appearing boy
- Skin: No petechiae, purpura, or ecchymoses
- Joints: No hemarthroses or swelling
- Lymph: Enlarged tonsils
- Otherwise unremarkable
Laboratory Workup
Initial Coagulation Studies:
| Test | Result | Reference Range | Interpretation |
|---|---|---|---|
| PT | 12.1 seconds | 11-14 seconds | Normal |
| INR | 1.0 | 0.8-1.2 | Normal |
| PTT | 58 seconds | 25-35 seconds | Prolonged |
| Platelet Count | 285,000/mcL | 150,000-400,000 | Normal |
| Bleeding Time | 4 minutes | 2-9 minutes | Normal |
Systematic Approach to Prolonged PTT
Step 1: Understand What PT and PTT Measure
| Pathway | Test | Factors Assessed |
|---|---|---|
| Extrinsic | PT | Factor VII (+ common pathway: X, V, II, fibrinogen) |
| Intrinsic | PTT | Factors XII, XI, IX, VIII (+ common pathway) |
| Common | Both | Factors X, V, II (prothrombin), I (fibrinogen) |
Isolated prolonged PTT (normal PT) indicates:
- Deficiency or inhibitor affecting intrinsic pathway factors (XII, XI, IX, VIII)
- Does NOT affect common pathway (or PT would also be prolonged)
Step 2: Perform Mixing Study
A mixing study determines whether the prolonged PTT is due to a factor deficiency or an inhibitor:
- Patient plasma is mixed 1:1 with normal pooled plasma
- The mixture is tested immediately and after 1-2 hours incubation
Mixing Study Results:
| Condition | Result |
|---|---|
| Immediate mix PTT | 32 seconds (corrected to normal) |
| Incubated mix (2 hours, 37C) | 34 seconds (remains corrected) |
Interpretation:
- Correction = Factor Deficiency (normal plasma provides the missing factor)
- No correction = Inhibitor present (antibody inhibits factor in mixed sample)
This patient's mixing study CORRECTS, indicating a factor deficiency, NOT an inhibitor.
Step 3: Identify Which Factor is Deficient
Individual Factor Assays:
| Factor | Level | Reference Range |
|---|---|---|
| Factor VIII | 85% | 50-150% |
| Factor IX | 78% | 50-150% |
| Factor XI | 82% | 50-150% |
| Factor XII | < 5% | 50-150% |
Diagnosis
Factor XII (Hageman Factor) Deficiency
Clinical Significance
CRITICAL TEACHING POINT: Factor XII deficiency causes a markedly prolonged PTT but does NOT cause clinical bleeding.
Why Factor XII Deficiency Doesn't Cause Bleeding:
- Factor XII is important for in vitro (test tube) coagulation
- In vivo, coagulation is primarily initiated by tissue factor (extrinsic pathway)
- Factor XII is not required for normal hemostasis
- Patients with factor XII deficiency have NORMAL surgical outcomes
Historical Note:
- John Hageman, in whom the deficiency was first described, had no bleeding problems
- Ironically, he died of pulmonary embolism (thrombosis, not bleeding)
Factors That Prolong PTT Without Bleeding Risk
| Factor Deficiency | PTT | Bleeding Risk |
|---|---|---|
| Factor XII | Very prolonged | NONE |
| Prekallikrein | Prolonged | None |
| High-molecular-weight kininogen | Prolonged | None |
| Factor VIII (Hemophilia A) | Prolonged | SEVERE |
| Factor IX (Hemophilia B) | Prolonged | SEVERE |
| Factor XI | Prolonged | Variable (often mild) |
Conditions That Prolong PTT (Differential Diagnosis)
Factor Deficiencies (mixing study corrects):
- Factor VIII deficiency (Hemophilia A) - DOES bleed
- Factor IX deficiency (Hemophilia B) - DOES bleed
- Factor XI deficiency - Variable bleeding
- Factor XII, prekallikrein, HMWK - NO bleeding
Inhibitors (mixing study does NOT correct):
- Lupus anticoagulant (antiphospholipid antibodies)
- Paradoxically causes thrombosis, not bleeding
- PTT prolonged in vitro only
- Specific factor inhibitors (e.g., acquired Factor VIII inhibitor)
- DOES cause bleeding
Other:
- Heparin contamination (common in hospitalized patients)
- von Willebrand disease (vWF carries Factor VIII)
Management for This Patient
Recommendations:
- Surgery can proceed as planned - Factor XII deficiency does not increase bleeding risk
- No factor replacement needed
- No special precautions required
- Document in medical record to avoid future unnecessary workups
- Family screening optional (autosomal recessive inheritance)
Counsel Family:
- Reassure that this is a benign laboratory finding
- No clinical bleeding disorder
- Future surgeries and procedures are safe
- If asked, can explain that "the blood test measures clotting in a test tube, but your son clots normally in his body"
Clinical Pearl
An isolated prolonged PTT must always be investigated with a mixing study to differentiate factor deficiency from an inhibitor. If the mixing study corrects, factor assays identify the specific deficiency. Factor XII deficiency is clinically benign and does not cause bleeding - surgery can proceed safely. Similarly, lupus anticoagulant prolongs PTT but causes thrombosis, not bleeding. Always correlate laboratory findings with clinical bleeding history. A patient with severe prolonged PTT but no bleeding history likely has Factor XII deficiency or lupus anticoagulant - neither requires treatment for bleeding prevention. In contrast, hemophilia A and B (Factor VIII and IX deficiencies) cause severe bleeding and require factor replacement before procedures.